T-細(xì)胞可誘導(dǎo)共刺激分子(ICOS)重組蛋白
Recombinant Inducible T-Cell Co Stimulator (ICOS)
CD278; AILIM; Inducible T-Cell Costimulator; Activation-Inducible Lymphocyte Immunomediatory Molecule
- 編號RPA777Ra01
 - 物種Rattus norvegicus (Rat,大鼠)相同的名稱,不同的物種。
 - 來源原核表達(dá)
 - 宿主E.coli
 - 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
 - 亞細(xì)胞定位細(xì)胞膜
 - 預(yù)測分子量12.2kDa
 - 實(shí)際分子量13kDa(差異分析請參閱說明書)
 - 片段與標(biāo)簽Gln39~Glu133 (Accession # Q9R1T7) with N-terminal His Tag
 - 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
 - 性狀凍干粉
 - 純度> 95%
 - 等電點(diǎn)6.01
 - 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載英文說明書 中文說明書
 - 規(guī)格10μg50μg200μg1mg5mg
 - 價格¥ 984¥ 2460¥ 4920¥ 14760¥ 36900
 - 欲了解實(shí)際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
序列

用法
pH7.4,?containing?0.01%?SKL,?5%?Trehalose
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種:Rattus norvegicus (Rat,大鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| RPA777Ra01 | T-細(xì)胞可誘導(dǎo)共刺激分子(ICOS)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAA777Ra01 | T-細(xì)胞可誘導(dǎo)共刺激分子(ICOS)多克隆抗體 | WB | 
| LAA777Ra71 | T-細(xì)胞可誘導(dǎo)共刺激分子(ICOS)多克隆抗體(生物素標(biāo)記) | WB | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Archives of Dermatological Research | Increased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosis[Pubmed: 23053221] | 
| DNA Cell Biol. | Effect of soluble inducible costimulator level and its polymorphisms on age-related macular degeneration.[Pubmed: 24083358] | 
| Rheumatology | Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis[Pubmed: 23024058] | 
| Br J Haematol | Inducible T‐cell co‐stimulator (ICOS) and ICOS ligand are novel players in the multiple‐myeloma microenvironment[Pubmed:34954822] | 
| Diagnostics (Basel) | Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases[Pubmed:35328257] | 



